Risks of chemical substances to human health and the environment RIVM is developing methods to identify new and emerging risks of chemical substances to workers, consumers and the environment.
Use of other needles in Dutch Immunisation Programme as a precaution As a result of the EenVandaag broadcast regarding the safety of injection needles, and after consultation with the Dutch Inspection for Health Care (IGZ), RIVM advises against the use of needles so
New insights on ammonia emissions Calculated ammonia emissions in the Netherlands are still declining. However, emissions overall are greater than previously assumed.
Harmful substances in e-cigarettes assessed While e-cigarettes are less harmful to health than tobacco cigarettes, the vapour from an e-cigarette contains substances and chemical impurities in concentrations that could be detrimental to heal
Reduced-sodium lunches result in decreased daily dietary sodium intakes Consumption of reduced-sodium foods over a 3-week period was well accepted by uninformed participants in an experimental real-life canteen setting.
Utrecht Side Event International One Health Congress Scientists and policy makers from around the world will visit research institutes and companies in the field of Life Sciences in the Utrecht region on March 18th.
Big Data gives more insight into the health impacts of air pollution Long-term exposure to particulate air pollution and nitrogen dioxide has been found to be associated with total mortality and mortality from respiratory diseases and lung cancer in the Netherlands.
Drinking water protection files are steadily progressing Local and provincial authorities, drinking water supply companies and water resource managers authority are making progress with the assessment of the current and future risks for the quality of ex
New bacterium in ticks Last year, a man was treated at the Amsterdam Academic Medical Centre (AMC) after being bitten by a tick and becoming infected with a strain of the Borrelia bacterium not previously encountered in
Regional differences in testing rates underestimate incidence of LGV epidemic Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.